AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2025
Mar 5, 2025
29821_dirs_2025-03-05_b0a385de-f939-4848-9164-63be7b4a859f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2025-03-03
Reporting Person: Woodworth Emily (SVP, Global Controller and CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-03 | Common Stock | M | 5949.0000 | $37.5000 | Acquired | 8063.0000 | Direct |
| 2025-03-03 | Common Stock | S | 7149.0000 | $104.9748 | Disposed | 914.0000 | Direct |
| 2025-03-04 | Common Stock | S | 482.0000 | $104.6300 | Disposed | 432.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | Stock Option (Right to Buy) | $37.5000 | M | 5949.0000 | Disposed | 2031-02-17 | Common Stock (5949.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.85 to $105.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.